EverHint Signal — EMA10 × EMA30 Crossover — November 24, 2025
What This Signal Is (Quick)
EMA10 × EMA30 Crossover tracks fresh shifts in short-term momentum:
- Buy signal (EMA10_x_EMA30_Buy) – EMA10 crosses above EMA30
Short-term momentum overtakes the medium trend, often marking early upside inflection. - Sell signal (EMA10_x_EMA30_Sell) – EMA10 crosses below EMA30
Short-term momentum slips under the medium trend, often flagging exhaustion or early downside.
Compared with slower crossovers (like EMA10 × SMA50), this one fires more often and reacts sooner, which is great for catching quick swings but also means more whipsaws in choppy markets.
This is an experimental scanner, intended for 1–4 week swing trades, not a long-term allocation model.
How We Ranked Today (Reader Version)
Default ranking per instructions is by RSI(14), with volume as fallback. For this crossover:
- Buy signals – lower RSI is prioritized (more “early” / less overbought).
- Sell signals – higher RSI is prioritized (more overbought and stretched).
To combine buys and sells into a single “Top 10” list, a simple RSI-based ranking metric was used:
- For buys: rank by RSI ascending
- For sells: rank by (100 − RSI) ascending (i.e., higher RSI → stronger sell)
Overlays used:
- Net Insider Flow (90d) – P (buys) minus S (sales) in dollar value
- Days → Earnings – nearest future earnings date from the calendar
- Liquidity – 20-day average dollar volume (adv20_dollars)
- Market context – indices and VIX from the markets snapshot
Signals are for education and back-testing, not trade recommendations.
📈 Buy-Side Signals — Top Names Within Overall Top 10
(Subset of the combined Top 10 where the signal is a Buy.)
| Rank | Ticker | Company | Sector | Last ($) | RSI(14) | Insider Net (USD) | Days → Earnings | Liquidity (20d $) |
|---|---|---|---|---|---|---|---|---|
| 1 | BMRN | BioMarin Pharmaceutical Inc. | Healthcare | 55.50 | 58.8 | 0 | 64 (amc) | 177.6M |
| 2 | ARE | Alexandria Real Estate Equities, Inc. | Real Estate | 115.24 | 58.8 | 0 | 76 (amc) | 144.0M |
| 3 | OTIS | Otis Worldwide Corporation | Industrials | 95.80 | 65.0 | 0 | 81 (bmo) | 227.4M |
| 4 | EXAS | Exact Sciences Corporation | Healthcare | 100.90 | 67.8 | –1.30M | 86 (amc) | 700.9M |
Notes:
- BMRN and ARE offer relatively moderate RSI values among the buy group, suggesting trend continuation without full overbought blow-off.
- EXAS stands out for liquidity (≈701M USD 20-day dollar volume) but also shows ~–1.3M USD net insider selling over the last 90 days.
- All buys have earnings more than 60 days away, keeping immediate event risk modest.
📉 Sell-Side Signals — Top Names Within Overall Top 10
(Subset of the combined Top 10 where the signal is a Sell.)
| Rank | Ticker | Company | Sector | Last ($) | RSI(14) | Insider Net (USD) | Days → Earnings | Liquidity (20d $) |
|---|---|---|---|---|---|---|---|---|
| 1 | KMI | Kinder Morgan, Inc. | Energy | 26.82 | 65.4 | +25.0M | 65 (amc) | 382.1M |
| 2 | CMG | Chipotle Mexican Grill, Inc. | Consumer Cyclical | 69.73 | 60.1 | 0 | 80 (amc) | 757.6M |
| 3 | MDT | Medtronic plc | Healthcare | 88.19 | 57.0 | 0 | 85 (bmo) | 375.1M |
| 4 | KVUE | Kenvue Inc. | Consumer Defensive | 19.32 | 61.8 | 0 | 74 (bmo) | 142.0M |
| 5 | PEP | PepsiCo, Inc. | Consumer Defensive | 145.50 | 72.3 | 0 | 80 (bmo) | 709.3M |
| 6 | MSI | Motorola Solutions, Inc. | Technology | 548.46 | 73.8 | 0 | 70 (amc) | 381.2M |
Notes:
- KMI combines a sell signal with positive net insider flow (~+25M USD), a contrarian twist that can mean either profit-taking into strength or longer-term confidence beneath short-term froth.
- PEP and MSI have some of the highest RSIs in the universe today, which is exactly what you’d expect to surface on the sell side of a crossover strategy.
- Liquidity is strong across the board; all names trade above ~140M USD in 20-day average dollar volume, making them workable for larger swing positions.
Recent Headlines Snapshot (Selected Top 10 Names)
From the last few days of news flow for these symbols:
- PEP — PepsiCo, Inc.
Recent articles focus on currency and tariff headwinds, soft North American beverage volumes, and the importance of upcoming quarters to defend EPS targets. Institutional ownership updates also highlight continued interest from large funds. - KMI — Kinder Morgan, Inc.
Coverage has emphasized broader energy sector trends, including pipeline capacity, long-term demand expectations, and positioning for potential shifts in energy pricing, with Kinder Morgan often cited as a key infrastructure play. - EXAS — Exact Sciences Corporation
Headlines continue to emphasize its role in cancer screening and diagnostics, with investors weighing growth prospects against execution and valuation after a strong run.
(Headlines are summarized and lightly paraphrased from recent articles; URLs are kept clean and tracking-free when shared.)
Field Notes
A few interesting structural details from today’s scan:
- Style mix in the Top 10
The list cuts across defensive (PEP, KVUE), growth / diagnostics (EXAS, BMRN), infrastructure (KMI, ARE), and tech/communications (MSI, OTIS), showing that this EMA crossover is catching broad trend shifts, not just one style factor. - Earnings timing
Every name in the Top 10 has earnings roughly 60–86 days out, so this is mostly about trend and sentiment, not pre-earnings speculation. That’s useful if you want swing trades that are less dominated by a single binary event. - Insider behavior
- KMI: sizeable positive net buying (~+25M USD) over the last 90 days.
- EXAS: net selling (~–1.3M USD) after a big move, typical of management de-risking.
- Others: essentially neutral over the recent window.
- RSI context
Buys in the high-50s to high-60s range suggest momentum continuation entries, not deep value or oversold fades. Sells in the low-60s to mid-70s range suggest profit-taking zones in extended uptrends rather than outright breakdowns (yet).
Vlad’s Take (EverHint)
Using today’s markets snapshot:
- S&P 500 closed around +1.0%, Nasdaq Composite +1.7%, and Dow Jones +0.2%+, a clearly bullish, risk-on session with tech leadership.
- Russell 2000 gained about +1.8%, showing broad participation beyond mega-caps.
- VIX finished near 20.6, down roughly 9% on the day, signaling easing fear but still in the elevated zone rather than full complacency.
In that environment, EMA10 × EMA30 crossovers tend to work best on buy signals riding strong trends (like BMRN, ARE, OTIS, EXAS), while sell signals on extended names (PEP, MSI, KMI) can make sense as risk-trims or partial profit-taking, not necessarily outright shorts.
Given the still-elevated VIX, this is a place for:
- Tiered entries instead of “all-in”
- Modest position sizes
- Clearly defined exit rules if the crossover fails and price mean-reverts faster than expected
Independent, data-driven signals.
No hype. No promotions. Just experimental market research from EverHint.
This is not financial advice. Do your own due diligence.
See https://www.everhint.com/disclaimer/
https://www.everhint.com/faqs/